Skip to main content
SpringerLink
Log in

High-Level Oxacillin and Gentamycin Resistance with Reduced Susceptibility to Vancomycin in Staphylococcus aureus-Carrying mecA and femA Gene Complex

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Staphylococcus aureus oxiva 10 and oxiva 14 strains clinically isolated from diabetic patients were resistant to gentamycin and oxacillin The minimal inhibitory concentrations (MICs) of oxacillin and gentamycin were 720 and >2048 μg/mL, respectively, for oxiva 10 and 680 and 400 μg/mL. respectively, for oxiva 14; both strains carry mecA and femA genetic determinants in their genomes. In addition, both are vancomycin-intermediate Staphylococcus aureus (VISA) isolates. The addition of vancomycin led to significant decreases in oxacillin resistance of both oxiva 10 and oxiva 14 strains, whereas the addition of vancomycin to gentamycin plates showed a decrease in gentamycin resistance of non-high-level gentamycin-resistant (non-HLGR) oxiva 14 and indifference in gentamycin resistance in HLGR oxiva 10. Transmission electron microscopy of representative strains unveils a remarkable increase in the thickness of the cell wall, indicating that thickening of the cell wall is a common phenotype associated with vancomycin resistance in VISA isolates. The present study reports that the rate of synergism and synergistic effect in the combination vancomycin–gentamycin vary according to the MICs of gentamycin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

Literature Cited

  1. Anandi C, Alaguraja D, Natarajan V, et al. (2004) Bacteriology of Diabetic foot lesions. Indian J Med Microbiol 22 (3):175–178

    Google Scholar 

  2. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM (2003) Prevalence of methicillin resistant Staphylococcus aureus a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21:49–51

    Google Scholar 

  3. Aritaka N, Hanaki H, Cui L, Hiramatsu K (2001) Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother 45:1292–1294

    Article  PubMed  CAS  Google Scholar 

  4. Bagdade JD, Root RK, Bulger RD (1974) Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23:9–15

    PubMed  CAS  Google Scholar 

  5. Cooper G, Platt R (1982) Staphylococcus aureus bacteremia in diabetic patients: Endocarditis and mortality. Am J Med 73:658–662

    Article  PubMed  CAS  Google Scholar 

  6. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin resistant and methicillin susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59

    Article  PubMed  Google Scholar 

  7. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K (2000 ) Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 44:2276–2285

    Article  PubMed  CAS  Google Scholar 

  8. Cui L, Ma X, Sato K, et al. (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5–14

    Article  PubMed  CAS  Google Scholar 

  9. Dang CN, Prasad YDM, Boulton AJM, Jude EB (2002) Methicillin resistant Staphylococcus aureus in the diabetic foot clinic: the problem is getting worse. Diabetologia 45:A4

    Google Scholar 

  10. Fani R, Damiani G, Di Serio Gallori E, Grifoni A, Bazzicalupo M (1993) Use of random amplified polymorphic DNA (RAPD) for generating specific DNA probes for microorganisms. Mol Ecol 2:243–250

    PubMed  CAS  Google Scholar 

  11. Franklin D, Lowy MD (1998) Staphylococcus aureus infections. N Engl J Med 339(8):520–532

    Google Scholar 

  12. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K (1998) Activated cell wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199–209

    Article  PubMed  CAS  Google Scholar 

  13. Hartman BJ, Tomasz A (1984) Low affinity penicillin binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bactriol 158:513–516

    CAS  Google Scholar 

  14. Hiramatsu K, Hanaki H, Ito T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136

    Article  PubMed  CAS  Google Scholar 

  15. Hiramatsu K, Cui L, Kuroda M, Ito T (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9:486–493

    Article  PubMed  CAS  Google Scholar 

  16. Houlihan HH, Mercier RC, Rybak MJ (1997) Pharmacodynamics of vancomycin alone and in combination with gentamycin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin platelet clots in an in vitro infection model. Antimicrob Agent Chemother 41:2497–2501

    CAS  Google Scholar 

  17. NCCLS (2000) National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disk Susceptibility Test, 7th ed. Approved Standard M2-A7. NCCLS, Villanova, PA

    Google Scholar 

  18. O’Brien IAD, Corrall RJM (1988) Epidemiology of diabetes and its complications. N Engl JMed 318:1619–1620

    CAS  Google Scholar 

  19. Oliveira DC, de Lencastre H (2002) Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother 46:2155–2161

    Article  PubMed  CAS  Google Scholar 

  20. Saulnier P, Bourneix C, Prevost G, Andremont A (1993) Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 31:982–985

    PubMed  CAS  Google Scholar 

  21. Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999) The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 340:517–523

    Article  PubMed  CAS  Google Scholar 

  22. Small PM, Chambers HF (1990) Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34:1227–1231

    PubMed  CAS  Google Scholar 

  23. Song JH, Hiramatsu K, Suh JY, et al. (2004) Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agent Chemother 48:4926–4928

    Article  CAS  Google Scholar 

  24. Takashi I, Ryoichi O, Chieko S, Toyoji O, Akio K, Matsuhisa I (2001) Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol 39:3115–3121

    Article  Google Scholar 

  25. Weller TMA (1999) The distribution of mecA, mecR1 and mecl and sequence analysis of mecl and the promotor region in Staphylococci expressing resistance to methicillin. J Antimicrob Chemother 43:15–22

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology, Gulbarga University, Gulbarga-06, Karnataka, India

    S. Raju & R. Kelmani Chandrakanth

  2. Department of Neuromicrobiology, NIMHANS, Bangalore-029, Karnataka, India

    S. A. Patil

Authors
  1. S. Raju
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Kelmani Chandrakanth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. A. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Kelmani Chandrakanth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raju, S., Kelmani Chandrakanth, R. & Patil, S.A. High-Level Oxacillin and Gentamycin Resistance with Reduced Susceptibility to Vancomycin in Staphylococcus aureus-Carrying mecA and femA Gene Complex. Curr Microbiol 54, 429–434 (2007). https://doi.org/10.1007/s00284-006-0584-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00284-006-0584-6

Keywords

Search

Navigation